Geron is a late-stage clinical biopharmaceutical company focused on the development and potential commercialization of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.

Biotechnology

Health & Wellness

Geron

Geron's headquarters in Menlo Park, CA, United States

Michelle Robertson

Stewart Hackney

Melissa A. Kelly Behrs

Andrew J. Grethlein

Joe Denton

Peter A. Avalos

Ying Wan

Rachel Williams

Mary Foster

Dawn Liu Winn

Joseph Eid

Michael Yamada

Shannon Odam

Agnieszka Cieplinska

Alan Chan

Katherine Harmon

Kathy Lindner

Casey Flores

Greg Angelovic

Jimmy Evans

Shannon Maryman

Dawn C. Bir

Elizabeth G. O'Farrell

Gaurav Aggarwal

John F. McDonald

V. Bryan Lawlis

Susan M. Molineaux

Robert J. Spiegel

This department focuses on maintaining and nurturing relationships with key clients to ensure their satisfaction and retention.

Account Management

This department manages key accounts and relationships within the oncology sector to drive business growth.

Oncology Accounts

The Clinical Operations Team at Geron is responsible for overseeing and managing the company's clinical trials, ensuring they are conducted efficiently, compliantly, and within established timelines. This team works collaboratively to plan, execute, and monitor clinical studies, support regulatory submissions, maintain quality assurance, and provide critical scientific and medical insights to advance the development of Geron's lead telomerase inhibitor, imetelstat, for the treatment of hematologic myeloid malignancies.

Clinical Operations Team

This department manages regulatory operations, clinical science, market access, and compliance to ensure effective oversight and implementation of clinical and regulatory strategies.

Regulatory and Clinical Affairs

This department focuses on developing and implementing strategies to drive sales, marketing, and project management initiatives.

Commercial Strategy and Operations

The Medical and Clinical Teams at Geron are responsible for the development, clinical evaluation, and potential commercialization of imetelstat, a telomerase inhibitor targeting hematologic myeloid malignancies. Their duties include designing and overseeing clinical trials, analyzing clinical data, ensuring regulatory compliance, developing scientific communications, managing patient services and medical affairs, and strategizing real-world evidence and field medical operations to support the drug's pathway from trials to market.

Medical and Clinical Teams

Geron

Org chart

Board & advisors

Teams

Account Management

Oncology Accounts

Clinical Operations Team

Regulatory and Clinical Affairs

Commercial Strategy and Operations

Medical and Clinical Teams

Offices

Geron

Org chart

Board & advisors

Teams

Account Management

Oncology Accounts

Clinical Operations Team

Regulatory and Clinical Affairs

Commercial Strategy and Operations

Medical and Clinical Teams

Offices

Related companies